Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty
Evaluating the Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty: A Randomized Control Trial
University of Alabama at Birmingham
60 participants
Apr 20, 2026
INTERVENTIONAL
Conditions
Summary
The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid
Eligibility
Inclusion Criteria1
- Skeletally mature patients (ages 18-79) undergoing primary total shoulder arthroplasty
Exclusion Criteria1
- Patients with Cancer, venous thromboembolism, stroke, heart disease, pregnant or nursing, allergic to TXA, current tobacco use, anticoagulants other than aspirin.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
one group of subjects will receive oral tranexamic acid and the other will receive oral placebo
one group of randomized subjects will receive placebo and the other will receive oral tranexamic acid
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06902714